CrossLife Technologies Inc. is a biotechnology startup founded in 2010 with the mission of improving health through innovative molecular diagnostics for infectious and non-communicable diseases. The company's focus on DNA/RNA-based diagnostic technologies and products has attracted $224.93K in grant investment from the National Science Foundation as of 12 June 2017. Led by a management team of experienced diagnostic kit and test development personnel, CrossLife Technologies is committed to providing high-quality, reliable tools for molecular diagnostics to improve healthcare worldwide. Their dedication to innovation, compliance with regulations, effective quality programs, and responsiveness to customer feedback positions them as a promising player in the life sciences industry.
CrossLife Technologies Inc.
Carlsbad, United States
6 employees
Grant
Total: $224.93K
Biotechnology, Health Care
General Information
Get notified when CrossLife Technologies Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track CrossLife Technologies Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About CrossLife Technologies Inc.
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | •••••• | 1 |
|
12 Jun 2017 |
CrossLife Technologies Inc. Alternatives & Competitors
We develop devices that drive advancements and facilitate groundbreaking research in the field of mo...
Delivering one-of-a-kind PCR solutions tailored to customer needs and contributing to a better world...
LGC Clinical Diagnostics | Science for a Safer World
FAQ About CrossLife Technologies Inc.
Don't just browse. Track.
Signal Tracker monitors CrossLife Technologies Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.